A. Oltra

725 total citations
18 papers, 394 citations indexed

About

A. Oltra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A. Oltra has authored 18 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in A. Oltra's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). A. Oltra is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). A. Oltra collaborates with scholars based in Spain, Chile and Mexico. A. Oltra's co-authors include María A. Pastor, Jorge Aparicio, Joaquín Montalar, B. Munárriz, José Gómez‐Codina, Ana Santaballa, Gaspar Reynés, I. Maestu, Constantino Herranz and Jorge Matías‐Guiu and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

A. Oltra

17 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Oltra Spain 11 237 116 104 83 65 18 394
Burton Needles United States 10 330 1.4× 104 0.9× 44 0.4× 48 0.6× 45 0.7× 17 544
Anne Cowppli‐Bony France 12 159 0.7× 106 0.9× 75 0.7× 30 0.4× 79 1.2× 17 351
Amanda Parkes United States 12 222 0.9× 132 1.1× 56 0.5× 50 0.6× 28 0.4× 36 391
S Schryber United States 8 258 1.1× 77 0.7× 82 0.8× 107 1.3× 19 0.3× 9 435
Alejandro Ruíz-Patiño Colombia 11 141 0.6× 130 1.1× 63 0.6× 83 1.0× 34 0.5× 43 368
Anne-Birgitte Jacobsen Norway 13 184 0.8× 141 1.2× 78 0.8× 84 1.0× 32 0.5× 30 452
S.A.M. van de Schans Netherlands 14 247 1.0× 115 1.0× 209 2.0× 17 0.2× 74 1.1× 26 462
Ülkü Yalçıntaş Arslan Türkiye 11 223 0.9× 147 1.3× 106 1.0× 112 1.3× 37 0.6× 52 470
A Bataillard France 11 168 0.7× 126 1.1× 99 1.0× 25 0.3× 25 0.4× 30 399
David L. Roseman United States 13 246 1.0× 149 1.3× 114 1.1× 125 1.5× 94 1.4× 22 505

Countries citing papers authored by A. Oltra

Since Specialization
Citations

This map shows the geographic impact of A. Oltra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Oltra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Oltra more than expected).

Fields of papers citing papers by A. Oltra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Oltra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Oltra. The network helps show where A. Oltra may publish in the future.

Co-authorship network of co-authors of A. Oltra

This figure shows the co-authorship network connecting the top 25 collaborators of A. Oltra. A scholar is included among the top collaborators of A. Oltra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Oltra. A. Oltra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
García‐Alfonso, Pilar, Manuel Chaves-Conde, Andrés Muñoz, et al.. (2015). Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study. BMC Cancer. 15(1). 327–327. 10 indexed citations
2.
Alfonso, Pilar, Manuel Chaves-Conde, Andrés Muñoz, et al.. (2012). P-0256 Phase II Study to Evaluate Efficacy and Safety of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer (MCRC) Patients. Annals of Oncology. 23. iv103–iv104. 1 indexed citations
3.
Oltra, A., Ana Santaballa, B. Munárriz, María A. Pastor, & Joaquín Montalar. (2007). Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study. The Breast Journal. 13(6). 571–574. 31 indexed citations
4.
Aparicio, Jorge, José L. García-Puche, M. Lomas, et al.. (2006). Prognostic factors for relapse in stage I seminoma managed by surveillance or adjuvant carboplatin: A multivariate analysis on 588 cases. Journal of Clinical Oncology. 24(18_suppl). 4552–4552. 3 indexed citations
5.
Morales, Serafín, Manuel Ramos, Miguel Méndez, et al.. (2003). Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study. Cancer Chemotherapy and Pharmacology. 53(1). 75–81. 19 indexed citations
6.
7.
8.
Oltra, A., et al.. (1999). Metastatic Follicular Thyroid Carcinoma to the Kidney: A Case Report. Clinical Nuclear Medicine. 24(1). 48–50. 25 indexed citations
9.
Aparicio, Jorge, Ángel Segura, Joaquín Montalar, et al.. (1999). Long-term results after combined modality treatment for non-metastatic osteosarcoma. Medical Oncology. 16(4). 255–260. 12 indexed citations
10.
Aparicio, Jorge, et al.. (1999). ESHAP is an active regimen for relapsing Hodgkin's disease. Annals of Oncology. 10(5). 593–595. 94 indexed citations
11.
Maestu, I., Cathy A.J. Bosch, V. Giner, et al.. (1999). Carboplatin & gemcitabine in elderly patients with advanced non small cell lung cancer: preliminary results. European Journal of Cancer. 35. S261–S261. 3 indexed citations
12.
Maestu, I., María A. Pastor, José Gómez‐Codina, et al.. (1997). Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology. 8(6). 547–553. 68 indexed citations
13.
Aparicio, Jorge, A. Oltra, Joaquín Montalar, et al.. (1996). Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients. European Journal of Cancer. 32(10). 1739–1743. 22 indexed citations
14.
Matías‐Guiu, Jorge, et al.. (1996). [Descriptive epidemiology of transitory ischemic attack: a study in Muro d'Alcoi].. PubMed. 23(120). 422–4. 1 indexed citations
15.
Aparicio, Jorge, et al.. (1996). Extragonadal Nongestational Choriocarcinoma Involving the Lung: A Report of Three Cases. Respiration. 63(4). 251–253. 18 indexed citations
16.
Oltra, A., et al.. (1996). [Descriptive epidemiology of risk factors in cerebrovascular disorders:a study in Muro d'Alcoi].. PubMed. 23(120). 425–7.
17.
Matías‐Guiu, Jorge, et al.. (1994). Occurrence of Transient Ischemic Attacks in Alcoi: Descriptive Epidemiology. Neuroepidemiology. 13(1-2). 34–39. 23 indexed citations
18.
Oltra, A., et al.. (1990). [Transient global amnesia associated with subarachnoid hemorrhage].. PubMed. 5(1). 34–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Burton Needles Breakdown of academic impact, for papers by Anne Cowppli‐Bony Breakdown of academic impact, for papers by Amanda Parkes Breakdown of academic impact, for papers by S Schryber Breakdown of academic impact, for papers by Alejandro Ruíz-Patiño Breakdown of academic impact, for papers by Anne-Birgitte Jacobsen Breakdown of academic impact, for papers by S.A.M. van de Schans Breakdown of academic impact, for papers by Ülkü Yalçıntaş Arslan Breakdown of academic impact, for papers by A Bataillard Breakdown of academic impact, for papers by David L. Roseman
Rankless by CCL
2026